H.R. 2008 (119th)Bill Overview

Infant Formula Made in America Act of 2025

Taxation|Taxation
Cosponsors
Support
Bipartisan
Introduced
Mar 10, 2025
Discussions
Bill Text
Current stageCommittee

Referred to the House Committee on Ways and Means.

Introduced
Committee
Floor
President
Law
Congressional Activities
01 · The brief
Plain-English summaryWhat this bill actually does

The bill creates two federal tax incentives to expand U.S. infant formula production: a 30% investment tax credit for qualified domestic manufacturing projects and a $2-per-pound production credit for eligible domestic formula producers. Both credits target smaller producers (global revenue under $750 million), include certification, caps, recapture provisions, portability/elective-payment options, and limits on total and per-project allocations.

Why people may split

Progressives emphasize public-health and domestic-resilience benefits

Watch point

Relative to its intended legislative type, this bill is a well-specified tax-law enactment that establishes two targeted tax credits with defined eligibility, caps, timelines, and recapture rules and integrates those credits into the Internal Revenue Code.

The bill creates two federal tax incentives to expand U.S. infant formula production: a 30% investment tax credit for qualified domestic manufacturing projects and a $2-per-pound production credit for eligible domestic formula producers.

Both credits target smaller producers (global revenue under $750 million), include certification, caps, recapture provisions, portability/elective-payment options, and limits on total and per-project allocations.

The investment credit has per-project ($150M) and aggregate ($750M) caps and a 10-year construction commencement window; the production credit is limited to 18 million pounds per taxpayer per year and a five-year eligibility window.

Passage40/100

Moderately narrow, administrable incentives improve prospects, but fiscal cost, need for offsets, and Senate thresholds lower odds.

CredibilityAligned

Relative to its intended legislative type, this bill is a well-specified tax-law enactment that establishes two targeted tax credits with defined eligibility, caps, timelines, and recapture rules and integrates those credits into the Internal Revenue Code.

Contention48/100

Progressives emphasize public-health and domestic-resilience benefits

02 · What it does

Who stands to gain, and who may push back.

Likely benefits vs burdens50% / 50%
TaxpayersFederal agencies · Manufacturers

These are examples from the analysis, not a ranked list of the most-affected groups.

Likely helped
  • Potential benefitMay create construction and manufacturing jobs building and operating domestic formula facilities.
  • Potential benefitIncreases domestic infant formula supply, potentially reducing reliance on imports and shortages.
  • TaxpayersDirects incentives toward smaller and mid‑sized manufacturers by limiting eligibility to taxpayers under $750 million.
Likely burdened
  • Federal agenciesReduces federal revenues via new tax credits, with fiscal cost depending on program uptake.
  • ManufacturersTransferability could allow investors or third parties to capture credit value instead of manufacturers.
  • Potential burdenMay distort market incentives, favoring formula production investment over other infant nutrition priorities.
03 · Why people split

Why the argument around this bill splits.

Progressives emphasize public-health and domestic-resilience benefits
Progressive75%

Likely cautiously supportive.

The bill aims to rebuild domestic capacity and supply resilience while prioritizing smaller producers, which aligns with labor and public-health concerns, but it uses business tax incentives rather than direct public investment or strict labor/environmental conditions.

Leans supportive
Centrist80%

Generally favorable as a targeted, time-limited tool to shore up supply chains and domestic production.

Sees sensible guardrails (revenue cap, recapture, caps) but will want clearer cost estimates, administrative plans, and monitoring to prevent waste.

Leans supportive
Conservative50%

Mixed.

Supports domestic manufacturing and supply security but skeptical of targeted tax subsidies and federal intervention that pick specific industries.

May prefer broader tax relief or deregulation instead of new credits and federal certification programs.

Split reaction
04 · Can it pass?

The path through Congress.

Introduced

Reached or meaningfully advanced

Committee

Reached or meaningfully advanced

Floor

Still ahead

President

Still ahead

Law

Still ahead

Passage likelihood40/100

Moderately narrow, administrable incentives improve prospects, but fiscal cost, need for offsets, and Senate thresholds lower odds.

Scope and complexity
52%
Scopemoderate
52%
Complexitymedium
Why this could stall
  • No official cost or CBO estimate provided
  • Which agency/Secretary administers certification and criteria
05 · Recent votes

Recent votes on the bill.

No vote history yet

The bill has not accumulated any surfaced votes yet.

06 · Go deeper

Go deeper than the headline read.

Included on this page

Progressives emphasize public-health and domestic-resilience benefits

Moderately narrow, administrable incentives improve prospects, but fiscal cost, need for offsets, and Senate thresholds lower odds.

Unlocked analysis

Relative to its intended legislative type, this bill is a well-specified tax-law enactment that establishes two targeted tax credits with defined eligibility, caps, timelines, and recapture rules and integrates those cr…

Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.

Perspective breakdownsPassage barriersLegislative design reviewStakeholder impact map
Open full analysis